COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,254 Articles (22,733 medRxiv, 8,521 bioRxiv)

Most recent first Previous |  Page 592: Articles 5911-5920  | Next

SARS-CoV-2 S1 Subunit Booster Vaccination Elicits Robust Humoral Immune Responses in Aged Mice
Kim, E., Khan, M. S., Ferrari, A., Huang, S., Sammartino, J. C., Percivalle, E., Kenniston, T. W., Cassaniti, I., Baldanti, F., Gambotto, A.
10.1101/2022.10.25.513090 — Posted: 2022-10-26
Assessing SARS-CoV-2 evolution through the analysis of emerging mutations
Mitsigkolas, A., Pechlivanis, N., Psomopoulos, F. E.
10.1101/2022.10.25.513701 — Posted: 2022-10-26
Characterization of Three Variants of SARS-CoV-2 in vivo Shows Host-Dependent Pathogenicity in Hamsters
Toomer, G., Burns, W., Melendez, M., Garcia, L., Henry, G., Biancofiori, A., Geroge, A., Duffy, C., Chu, J., Sides, M., Munoz, M., Garcia, K., Nikolai-Yogerst, A., Peng, X., Westfall, L., Baker, R. O.
10.1101/2022.10.24.513632 — Posted: 2022-10-26
One for all - Human kidney Caki-1 cells are highly susceptible to infection with corona- and other respiratory viruses
Daniels, A., Fletcher, S. L., Kerr, H., Kratzel, A., Kriplani, N., Craig, N., Hastie, J. C., Digard, P., Davies, P., Thiel, V., Tait-Burkard, C.
10.1101/2022.10.25.513760 — Posted: 2022-10-25
Immunogenicity of the BA.5 Bivalent mRNA Vaccine Boosters
Collier, A.-r., Miller, J., Hachmann, N., McMahan, K., Liu, J., Bondzie, E., Gallup, L., Rowe, M., Shonberg, E., Thai, S., Barrett, J., Borducchi, E., Bouffard, E., Jacob-Dolan, C., Mazurek, C., Mutoni, A., Powers, O., Sciacca, M., Surve, N., VanWyk, H., Wu, C., Barouch, D.
10.1101/2022.10.24.513619 — Posted: 2022-10-25
Fever temperatures modulate intraprotein dynamics and enhance the binding affinity between monoclonal antibodies and the Spike protein from SARS-CoV-2
Kim, D. G., Kim, H. S., Choi, Y., Stan, R. C.
10.1101/2022.10.24.513610 — Posted: 2022-10-25
Impact of vaccination on the presence and severity of symptoms of hospitalised patients with an infection by the Omicron variant (B.1.1.529) of the SARS-CoV-2 (subvariant BA.1).
Beraud, G., Bouetard, L., Civljak, R., Michon, J., Tulek, N., Lejeune, S., Millot, R., Garchet-Beaudron, A., Lefebvre, M., Velikov, P., Festou, B., Abgrall, S., Lizatovic, I. K., Baldolli, A., Esmer, H., Blanchi, S., Froidevaux, G., Kapincheva, N., Faucher, J.-F., Duvnjak, M., Afsar, E., Svitek, L., Yarimoglu, S., Yarimoglu, R., Janssen, C., EPAULARD, o.
10.1101/2022.10.23.22281414 — Posted: 2022-10-25
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with critical COVID-19
Matuozzo, D., Talouarn, E., Marchal, A., Manry, J., Seeleuthner, Y., Zhang, Y., Bolze, A., Chaldebas, M., Milisavljevic, B., Zhang, P., Gervais, A., Bastard, P., Asano, T., Bizien, L., Barzaghi, F., Abolhassani, H., Abou Tayoun, A., Aiuti, A., Alavi Darazam, I., Allende, L., Alonso-Arias, R., Arias, A. A., Aytekin, G., Bergman, P., Bondesan, S., Bryceson, Y., Bustos, I., Cabrera-Marante, O., Carcel, S., Carrera, P., Casari, G., Chaibi, K., Colobran, R., Condino-Neto, A., Covill, L., El Zein, L., Flores, C., Gregersen, P., Gut, M., Haerynck, F., Halwani, R., Hancerli, S., Hammarstrom, L., Hatipoglu, N., Karbuz, A., Keles, S., Kyheng, C., Leon-Lopez, R., Franco, J. L., Mansouri, D., Martinez-Picado, J., Metin Akcan, O., Migeotte, I., Morange, P.-E., Morelle, G., Martin-Nalda, A., Novelli, G., Novelli, A., Ozcelik, T., Palabiyik, F., Pan-Hammarstrom, Q., Perez de Diego, R., Planas-Serra, L., Pleguezuelo, D., Prando, C., Pujol, A., Reyes, L. F., Riviere, J., Rodriguez-Gallego, C., Rojas, J., Rovere-Querini, P., Schluter, A., Shahrooei, M., Sobh, A., Soler-Palacin, P., Tandjaoui-Lambiotte, Y., Tipu, I., Tresoldi, C., Troya, J., van de Beek, D., Zatz, M., Zawadzki, P., Al-Muhsen, S. Z., Baris-Feldman, H., Butte, M., Constantinescu, S., Cooper, M., Dalgard, C., Fellay, J., Heath, J., Lau, Y.-L., Lifton, R., Maniatis, T., Mogensen, T., von Bernuth, H., Lermine, A., Vidaud, M., Boland, A., Deleuze, J.-F., Nussbaum, R., Kahn-Kirby, A., Mentre, F., Tubiana, S., Gorochov, G., Tubach, F., Hausfater, P., Meyts, I., Zhang, S.-Y., Puel, A., Notarangelo, L., Boisson-Dupuis, S., Su, H., Boisson, B., Jouanguy, E., Casanova, J.-L., Zhang, Q., Abel, L., Cobat, A.
10.1101/2022.10.22.22281221 — Posted: 2022-10-25
Development of criteria for cognitive dysfunction in post-COVID syndrome: the IC-CoDi-COVID approach
Matias-Guiu, J. A., Herrera, E., Gonzalez-Nosti, M., Krishnan, K., Delgado-Alonso, C., Diez-Cirarda, M., Yus, M., Martinez-Petit, A., Pagan, J., Ayala, J. L., Busch, R., Hermann, B. P.
10.1101/2022.10.21.22281239 — Posted: 2022-10-25
A SEIRD+V Model for the Effect of Vaccination and Social Distancing on SARS-CoV-2 Infection and Mortality
Sharifi, H., Jin, A. S.
10.1101/2022.10.23.22281416 — Posted: 2022-10-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).